Cell and Gene Therapy, Industry
April 6, 2022
Via: Biopharma DiveExcluding its coronavirus antibody drug, Regeneron has long counted Eylea as its top-selling product. Last year, net sales of the eye therapy totaled $5.8 billion in the U.S. and $3.6 billion across the rest of the world, where Regeneron’s partner […]
July 19, 2024
July 11, 2024
July 11, 2024